An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease (AMARANTH)

Trial Summary

Age Range
55 - 85 years
Conditions the trial is for
What the trial is testing?
Lanabecestat (LY3314814)
Could I receive a Placebo?
Yes
Enrollment Goal
2218
Trial Dates
Sep 30, 2014 - Oct 4, 2018
How long will I be in the trial?
Trial Phase
II / III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.